Wedge Capital Management L L P NC raised its stake in Davita Inc (NYSE:DVA) by 15.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 513,784 shares of the company’s stock after acquiring an additional 69,262 shares during the period. Wedge Capital Management L L P NC owned approximately 0.31% of Davita worth $36,802,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vigilant Capital Management LLC raised its holdings in Davita by 250.0% in the 2nd quarter. Vigilant Capital Management LLC now owns 2,100 shares of the company’s stock valued at $146,000 after acquiring an additional 1,500 shares in the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new position in Davita in the 2nd quarter valued at $206,000. Green Square Capital LLC acquired a new position in Davita in the 2nd quarter valued at $208,000. Seven Eight Capital LP acquired a new position in Davita in the 3rd quarter valued at $219,000. Finally, IFG Advisory LLC acquired a new position in Davita in the 2nd quarter valued at $213,000. 87.47% of the stock is owned by hedge funds and other institutional investors.
Davita stock opened at $67.66 on Friday. The company has a quick ratio of 1.88, a current ratio of 1.90 and a debt-to-equity ratio of 1.82. Davita Inc has a 52 week low of $52.51 and a 52 week high of $80.71. The firm has a market cap of $11.24 billion, a PE ratio of 20.38, a price-to-earnings-growth ratio of 0.86 and a beta of 1.09.
Several equities analysts have weighed in on DVA shares. Zacks Investment Research raised Davita from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a report on Monday, October 8th. JPMorgan Chase & Co. raised Davita from an “underweight” rating to a “neutral” rating in a report on Thursday, September 13th. Finally, ValuEngine raised Davita from a “hold” rating to a “buy” rating in a report on Tuesday, October 9th. Six analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. Davita currently has a consensus rating of “Buy” and an average price target of $82.50.
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Article: Intrinsic Value
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.